Exelixis (EXEL) Financials

$42.60 +0.19 (+0.45%)

Closing price 04:00 PM Eastern

Extended Trading

$42.38 -0.23 (-0.53%)

As of 06:51 PM Eastern

Annual Income Statements for Exelixis

This table shows Exelixis' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	1/3/2025	12/29/2023	12/30/2022	12/31/2021	1/1/2021	1/3/2020	12/28/2018	12/29/2017	12/30/2016	1/1/2016
Net Income / (Loss) Attributable to Common Shareholders	521	208	182	231	112	321	690	154	-70	-162
Consolidated Net Income / (Loss)	521	208	182	231	112	321	690	154	-70	-162
Net Income / (Loss) Continuing Operations	521	208	182	231	112	321	690	154	-70	-162
Total Pre-Tax Income	682	258	234	294	131	398	452	159	-70	-162
Total Operating Income	605	171	201	287	110	369	439	166	-28	-121
Total Gross Profit	2,092	1,758	1,553	1,382	951	935	827	437	185	33
Total Revenue	2,169	1,830	1,611	1,435	988	968	854	452	191	37
Operating Revenue	2,169	1,830	1,611	1,435	988	968	854	452	191	37
Total Cost of Revenue	76	73	58	53	36	33	26	15	6.55	3.90
Operating Cost of Revenue	76	73	58	53	36	33	26	15	6.55	3.90
Total Operating Expenses	1,488	1,587	1,352	1,095	841	565	389	272	213	155
Selling, General & Admin Expense	492	543	460	402	293	228	206	159	116	57
Research & Development Expense	910	1,044	892	694	548	337	182	112	96	96
Impairment Charge	52	0.00	0.00	-	-	-	-	-	-	-
Restructuring Charge	34	0.00	0.00	-	-	-	-	-	0.91	1.04
Total Other Income / (Expense), net	77	87	33	7.49	21	29	13	-7.33	-42	-40
Interest & Investment Income	77	87	33	7.67	20	28	13	4.88	2.58	0.79
Other Income / (Expense), net	-0.13	0.09	-0.20	-0.18	0.91	0.68	0.40	-3.54	-12	-0.38
Income Tax Expense	160	50	52	63	19	77	-238	4.35	0.00	0.06
Basic Earnings per Share	$1.80	$0.65	$0.57	$0.73	$0.36	$1.06	$2.32	$0.52	($0.28)	($0.77)
Weighted Average Basic Shares Outstanding	290.03M	318.15M	321.53M	314.88M	308.27M	302.58M	297.89M	293.59M	250.53M	209.23M
Diluted Earnings per Share	$1.76	$0.65	$0.56	$0.72	$0.35	$1.02	$2.21	$0.49	($0.28)	($0.77)
Weighted Average Diluted Shares Outstanding	296.13M	321.46M	324.56M	322.36M	318.00M	315.01M	312.80M	312.00M	250.53M	209.23M
Weighted Average Basic & Diluted Shares Outstanding	279.88M	303.19M	324.09M	319.45M	311.99M	305.39M	300.13M	296.60M	250.53M	209.23M

This table shows Exelixis' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/3/2025	9/27/2024	6/28/2024	3/29/2024	12/29/2023	9/29/2023	6/30/2023	3/31/2023	12/30/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	140	118	226	37	86	1.04	81	40	-30	73
Consolidated Net Income / (Loss)	140	118	226	37	86	1.04	81	40	-30	73
Net Income / (Loss) Continuing Operations	140	118	226	37	86	1.04	81	40	-30	73
Total Pre-Tax Income	185	155	293	49	103	5.82	100	48	-31	92
Total Operating Income	163	136	276	29	82	-18	78	29	-48	83
Total Gross Profit	547	522	620	404	458	453	452	394	408	396
Total Revenue	567	540	637	425	480	472	470	409	424	412
Operating Revenue	567	540	637	425	480	472	470	409	424	412
Total Cost of Revenue	20	17	18	21	22	19	18	14	16	15
Operating Cost of Revenue	20	17	18	21	22	19	18	14	16	15
Total Operating Expenses	384	386	344	375	376	471	374	366	456	314
Selling, General & Admin Expense	134	112	132	114	131	138	142	131	119	115
Research & Development Expense	249	223	211	228	245	333	233	234	337	199
Restructuring Charge	0.25	0.10	0.48	33	-	0.00	0.00	0.00	-	-
Total Other Income / (Expense), net	22	19	17	20	21	23	23	19	17	9.43
Interest & Investment Income	21	19	17	20	21	23	23	20	17	9.50
Other Income / (Expense), net	0.27	-0.03	-0.29	-0.09	-0.14	0.29	-0.01	-0.05	-0.34	-0.07
Income Tax Expense	45	37	67	12	18	4.78	19	8.25	-1.25	19
Basic Earnings per Share	$0.49	$0.41	$0.78	$0.12	$0.28	$0.00	$0.25	$0.12	($0.09)	$0.23
Weighted Average Basic Shares Outstanding	290.03M	285.62M	289.22M	300.76M	318.15M	315.50M	324.21M	324.42M	321.53M	322.15M
Diluted Earnings per Share	$0.47	$0.40	$0.77	$0.12	$0.28	$0.00	$0.25	$0.12	($0.10)	$0.23
Weighted Average Diluted Shares Outstanding	296.13M	291.48M	293.97M	305.53M	321.46M	319.25M	327.31M	326.28M	324.56M	325.07M
Weighted Average Basic & Diluted Shares Outstanding	279.88M	285.58M	285.25M	291.29M	303.19M	310.97M	318.38M	325.64M	324.09M	322.56M

This table details how cash moves in and out of Exelixis' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	1/3/2025	12/29/2023	12/30/2022	12/31/2021	1/1/2021	1/3/2020	12/28/2018	12/29/2017	12/30/2016	1/1/2016
Net Change in Cash & Equivalents	-46	-240	-161	343	53	-48	128	32	12	61
Net Cash From Operating Activities	700	333	363	401	209	527	416	166	210	-141
Net Cash From Continuing Operating Activities	700	333	363	401	209	527	416	166	210	-141
Net Income / (Loss) Continuing Operations	521	208	182	231	112	321	690	154	-70	-162
Consolidated Net Income / (Loss)	521	208	182	231	112	321	690	154	-70	-162
Depreciation Expense	29	26	21	14	9.14	8.35	4.92	1.19	1.00	1.41
Non-Cash Adjustments To Reconcile Net Income	223	247	233	149	113	60	45	17	48	28
Changes in Operating Assets and Liabilities, net	-73	-147	-73	7.52	-25	138	-324	-6.95	223	-26
Net Cash From Investing Activities	-117	-27	-524	-43	-131	-587	-298	37	-215	50
Net Cash From Continuing Investing Activities	-117	-27	-524	-43	-131	-587	-298	37	-215	50
Purchase of Property, Plant & Equipment	-28	-40	-28	-54	-30	-13	-33	-21	-1.70	-0.45
Acquisitions	-38	-123	-111	-10	0.00	-	-	-	-	-
Purchase of Investments	-928	-902	-1,451	-1,357	-1,070	-1,183	-558	-319	-369	-150
Sale and/or Maturity of Investments	877	1,038	1,065	1,379	969	608	293	377	156	199
Net Cash From Financing Activities	-629	-546	0.59	-15	-25	13	9.69	-170	16	152
Net Cash From Continuing Financing Activities	-629	-546	0.59	-15	-25	13	9.69	-170	16	152
Repurchase of Common Equity	-652	-550	0.00	0.00	-	-	-	-	-	-
Issuance of Common Equity	62	33	24	24	25	22	17	22	2.19	146
Other Financing Activities, net	-39	-29	-23	-39	-50	-9.90	-7.57	-6.56	14	10
Cash Income Taxes Paid	170	186	128	13	4.12	7.87	11	0.54	0.19	0.19

This table details how cash moves in and out of Exelixis' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/3/2025	9/27/2024	6/28/2024	3/29/2024	12/29/2023	9/29/2023	6/30/2023	3/31/2023	12/30/2022	9/30/2022
Net Change in Cash & Equivalents	-41	60	-61	-3.43	-134	-68	-78	39	-174	39
Net Cash From Operating Activities	240	271	120	69	11	117	121	84	74	110
Net Cash From Continuing Operating Activities	240	271	120	69	11	117	121	84	74	110
Net Income / (Loss) Continuing Operations	140	118	226	37	86	1.04	81	40	-30	73
Consolidated Net Income / (Loss)	140	118	226	37	86	1.04	81	40	-30	73
Depreciation Expense	7.64	7.45	7.33	6.38	6.53	6.30	6.04	6.86	5.95	5.66
Non-Cash Adjustments To Reconcile Net Income	48	88	32	55	27	135	29	56	132	46
Changes in Operating Assets and Liabilities, net	45	58	-146	-29	-109	-25	5.04	-19	-34	-15
Net Cash From Investing Activities	-93	-217	82	112	62	35	-74	-50	-246	-69
Net Cash From Continuing Investing Activities	-93	-217	82	112	62	35	-74	-50	-246	-69
Purchase of Property, Plant & Equipment	-3.98	-8.20	-6.57	-9.69	-13	-9.37	-5.94	-12	-9.72	-5.04
Acquisitions	-10	-1.00	-18	-8.50	-	-85	-1.50	-37	-103	-3.00
Purchase of Investments	-305	-375	-109	-138	-79	-183	-329	-312	-371	-387
Sale and/or Maturity of Investments	226	167	215	268	153	311	263	311	238	326
Net Cash From Financing Activities	-188	5.70	-262	-184	-206	-220	-125	4.59	-2.00	-2.04
Net Cash From Continuing Financing Activities	-188	5.70	-262	-184	-206	-220	-125	4.59	-2.00	-2.04
Repurchase of Common Equity	-190	-12	-264	-185	-209	-217	-124	0.00	-	-
Issuance of Common Equity	19	20	15	8.32	9.11	6.92	10	7.14	5.21	2.89
Other Financing Activities, net	-16	-2.17	-13	-6.99	-5.99	-9.75	-11	-2.56	-7.21	-4.93

This table presents Exelixis' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	1/3/2025	12/29/2023	12/30/2022	12/31/2021	1/1/2021	1/3/2020	12/28/2018	12/29/2017	12/30/2016	1/1/2016
Total Assets	2,948	2,942	3,071	2,616	2,137	1,886	1,422	655	596	332
Total Current Assets	1,468	1,318	1,619	1,835	1,445	1,011	897	485	469	179
Cash & Equivalents	217	263	501	647	319	267	315	183	152	142
Short-Term Investments	894	732	807	820	887	586	379	205	268	25
Accounts Receivable	265	237	215	283	161	119	163	81	40	5.18
Inventories, net	22	17	33	27	21	13	9.84	6.66	3.34	2.62
Prepaid Expenses	68	68	62	58	57	27	31	8.75	5.42	3.81
Plant, Property, & Equipment, net	119	129	111	104	67	49	51	26	2.07	1.43
Total Noncurrent Assets	1,361	1,496	1,342	677	625	826	474	145	125	152
Long-Term Investments	637	729	757	371	331	536	158	69	60	86
Goodwill	64	64	64	64	64	64	64	64	64	64
Noncurrent Deferred & Refundable Income Taxes	420	361	231	112	157	172	244	0.00	-	-
Other Noncurrent Operating Assets	240	342	291	131	73	53	8.29	12	1.23	2.31
Total Liabilities & Shareholders' Equity	2,948	2,942	3,071	2,616	2,137	1,886	1,422	655	596	332
Total Liabilities	703	678	583	406	258	200	135	370	506	473
Total Current Liabilities	404	394	324	338	205	143	105	115	269	52
Accounts Payable	38	34	33	24	24	12	11	9.58	6.57	6.40
Accrued Expenses	98	99	85	164	65	75	47	45	30	42
Customer Deposits	62	60	50	34	21	19	15	7.57	3.42	-
Current Employee Benefit Liabilities	110	93	77	62	51	37	32	21	20	3.63
Other Current Liabilities	95	108	79	53	44	-	-	-	-	-
Total Noncurrent Liabilities	300	284	259	68	54	57	29	255	238	421
Other Noncurrent Operating Liabilities	300	284	259	59	50	50	13	17	0.54	2.96
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,244	2,264	2,488	2,211	1,879	1,686	1,287	285	89	-141
Total Preferred & Common Equity	2,244	2,264	2,488	2,211	1,879	1,686	1,287	285	89	-141
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,244	2,264	2,488	2,211	1,879	1,686	1,287	285	89	-141
Common Stock	2,344	2,441	2,537	2,428	2,322	2,242	2,169	2,114	2,073	1,772
Retained Earnings	-99	-173	-34	-217	-448	-559	-880	-1,829	-1,983	-1,913
Accumulated Other Comprehensive Income / (Loss)	-1.35	-3.75	-15	-0.76	4.48	3.07	-0.70	-0.35	-0.42	-0.23

This table presents Exelixis' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/27/2024	6/28/2024	3/29/2024	9/29/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	2,960	2,773	2,804	2,977	3,142	3,143	2,961
Total Current Assets	1,550	1,477	1,292	1,443	1,591	1,638	1,842
Cash & Equivalents	258	198	260	397	464	541	675
Short-Term Investments	931	804	704	707	802	773	872
Accounts Receivable	270	397	241	248	233	234	215
Inventories, net	21	21	21	25	29	30	27
Prepaid Expenses	70	58	67	67	62	61	53
Plant, Property, & Equipment, net	124	130	127	121	115	116	108
Total Noncurrent Assets	1,286	1,165	1,384	1,413	1,437	1,390	1,012
Long-Term Investments	523	432	630	812	839	807	552
Goodwill	64	64	64	64	64	64	64
Noncurrent Deferred & Refundable Income Taxes	359	362	362	231	231	230	116
Other Noncurrent Operating Assets	340	308	329	306	304	290	280
Total Liabilities & Shareholders' Equity	2,960	2,773	2,804	2,977	3,142	3,143	2,961
Total Liabilities	685	653	676	629	615	588	470
Total Current Liabilities	394	346	373	377	340	328	302
Accounts Payable	59	29	26	26	26	33	31
Accrued Expenses	86	84	94	215	193	172	160
Customer Deposits	62	58	76	54	52	66	44
Current Employee Benefit Liabilities	91	72	73	81	68	57	67
Other Current Liabilities	96	103	104	-	-	-	-
Total Noncurrent Liabilities	291	308	303	252	275	261	168
Other Noncurrent Operating Liabilities	291	308	303	252	268	254	162
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,275	2,120	2,128	2,348	2,528	2,555	2,491
Total Preferred & Common Equity	2,275	2,120	2,128	2,348	2,528	2,555	2,491
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,275	2,120	2,128	2,348	2,528	2,555	2,491
Common Stock	2,362	2,325	2,392	2,488	2,531	2,559	2,513
Retained Earnings	-90	-200	-259	-126	11	5.80	-4.05
Accumulated Other Comprehensive Income / (Loss)	3.96	-5.15	-5.20	-14	-14	-9.29	-18

This table displays calculated financial ratios and metrics derived from Exelixis' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	1/3/2025	12/29/2023	12/30/2022	12/31/2021	1/1/2021	1/3/2020	12/28/2018	12/29/2017	12/30/2016	1/1/2016
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	18.49%	13.60%	12.27%	45.31%	2.04%	13.35%	88.70%	136.34%	415.05%	48.03%
EBITDA Growth	221.96%	-11.46%	-25.97%	149.86%	-68.27%	-14.78%	171.56%	639.70%	70.68%	47.12%
EBIT Growth	253.54%	-15.06%	-29.74%	158.16%	-70.02%	-15.73%	170.52%	508.59%	67.37%	44.66%
NOPAT Growth	235.37%	-12.03%	-30.40%	139.48%	-68.44%	-55.53%	315.14%	919.63%	76.84%	45.90%
Net Income Growth	150.89%	13.98%	-21.11%	106.71%	-65.18%	-53.48%	347.44%	319.63%	56.58%	38.10%
EPS Growth	170.77%	16.07%	-22.22%	105.71%	-65.69%	-53.85%	351.02%	275.00%	63.64%	42.54%
Operating Cash Flow Growth	110.00%	-8.08%	-9.53%	91.79%	-60.34%	26.76%	151.02%	-21.29%	249.17%	40.08%
Free Cash Flow Firm Growth	2,289.38%	-79.98%	-45.57%	292.72%	-88.65%	606.99%	-53.39%	-35.46%	287.54%	31.12%
Invested Capital Growth	-8.20%	27.57%	13.64%	8.95%	14.96%	-31.79%	353.12%	14.37%	-944.27%	3,917.47%
Revenue Q/Q Growth	4.18%	3.14%	-1.66%	0.00%	0.00%	1.22%	14.56%	10.36%	54.63%	7.47%
EBITDA Q/Q Growth	15.07%	197.80%	-42.02%	43.84%	-30.42%	-8.27%	20.58%	9.40%	63.47%	13.98%
EBIT Q/Q Growth	15.66%	317.92%	-45.05%	47.26%	-32.19%	-8.49%	20.29%	9.64%	58.22%	10.00%
NOPAT Q/Q Growth	13.54%	349.20%	-46.61%	44.08%	-28.85%	-48.25%	86.76%	-1.08%	71.48%	10.74%
Net Income Q/Q Growth	11.64%	125.65%	-40.74%	40.65%	-26.53%	-47.58%	87.28%	2.23%	50.90%	7.46%
EPS Q/Q Growth	12.10%	140.74%	-41.67%	41.18%	-27.08%	-47.69%	87.29%	-9.26%	54.10%	10.47%
Operating Cash Flow Q/Q Growth	48.84%	-15.92%	-5.91%	18.71%	-37.38%	11.28%	14.06%	-16.09%	132.76%	9.66%
Free Cash Flow Firm Q/Q Growth	82.94%	330.82%	-57.35%	69.40%	-72.68%	13.06%	554.58%	-30.27%	87.72%	3.66%
Invested Capital Q/Q Growth	-11.94%	24.82%	7.78%	7.17%	11.68%	-16.31%	163.16%	6.20%	-28.29%	10.30%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	96.49%	96.04%	96.41%	96.32%	96.33%	96.58%	96.91%	96.67%	96.58%	89.52%
EBITDA Margin	29.20%	10.75%	13.79%	20.91%	12.16%	39.11%	52.02%	36.15%	-15.83%	-278.05%
Operating Margin	27.88%	9.34%	12.51%	19.98%	11.14%	38.18%	51.40%	36.67%	-14.69%	-326.65%
EBIT Margin	27.87%	9.34%	12.49%	19.96%	11.24%	38.25%	51.45%	35.89%	-20.76%	-327.67%
Profit (Net Income) Margin	24.04%	11.35%	11.31%	16.10%	11.32%	33.17%	80.82%	34.09%	-36.68%	-435.12%
Tax Burden Percent	76.47%	80.68%	77.78%	78.55%	85.44%	80.63%	152.64%	97.26%	100.00%	100.03%
Interest Burden Percent	112.76%	150.62%	116.43%	102.68%	117.90%	107.55%	102.92%	97.66%	176.70%	132.75%
Effective Tax Rate	23.53%	19.32%	22.22%	21.45%	14.56%	19.37%	-52.64%	2.74%	0.00%	0.00%
Return on Invested Capital (ROIC)	89.30%	28.63%	39.39%	63.05%	29.42%	81.26%	508.06%	0.00%	0.00%	-732.81%
ROIC Less NNEP Spread (ROIC-NNEP)	85.91%	24.94%	38.08%	62.70%	28.21%	79.20%	504.97%	0.00%	0.00%	-787.86%
Return on Net Nonoperating Assets (RNNOA)	-66.17%	-19.89%	-31.63%	-51.75%	-23.15%	-59.67%	-420.29%	0.00%	0.00%	859.35%
Return on Equity (ROE)	23.13%	8.74%	7.76%	11.30%	6.27%	21.59%	87.77%	82.41%	272.77%	126.54%
Cash Return on Invested Capital (CROIC)	97.85%	4.40%	26.62%	54.48%	15.50%	119.06%	14.16%	0.00%	0.00%	-459.43%
Operating Return on Assets (OROA)	20.53%	5.69%	7.08%	12.05%	5.52%	22.38%	42.29%	25.96%	-8.56%	-37.16%
Return on Assets (ROA)	17.70%	6.91%	6.41%	9.72%	5.56%	19.41%	66.43%	24.66%	-15.13%	-49.34%
Return on Common Equity (ROCE)	23.13%	8.74%	7.76%	11.30%	6.27%	21.59%	87.77%	82.41%	272.77%	126.54%
Return on Equity Simple (ROE_SIMPLE)	23.23%	9.18%	7.33%	10.45%	5.95%	19.04%	53.60%	54.12%	-78.62%	114.87%
Net Operating Profit after Tax (NOPAT)	462	138	157	225	94	298	670	161	-20	-85
NOPAT Margin	21.32%	7.53%	9.73%	15.69%	9.52%	30.78%	78.45%	35.66%	-10.28%	-228.65%
Net Nonoperating Expense Percent (NNEP)	3.39%	3.69%	1.31%	0.35%	1.21%	2.06%	3.09%	-1.91%	-80.34%	55.05%
Return On Investment Capital (ROIC_SIMPLE)	20.60%	6.09%	6.30%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	3.51%	3.96%	3.59%	3.68%	3.67%	3.42%	3.09%	3.33%	3.42%	10.48%
SG&A Expenses to Revenue	22.69%	29.65%	28.54%	27.99%	29.71%	23.58%	24.17%	35.21%	60.66%	154.16%
R&D to Revenue	41.98%	57.05%	55.36%	48.34%	55.48%	34.82%	21.35%	24.79%	50.13%	259.20%
Operating Expenses to Revenue	68.61%	86.70%	83.90%	76.34%	85.18%	58.40%	45.52%	60.00%	111.27%	416.17%
Earnings before Interest and Taxes (EBIT)	604	171	201	286	111	370	439	162	-40	-122
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	633	197	222	300	120	378	444	164	-30	-103
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.32	3.30	2.08	2.62	3.31	3.07	4.51	31.56	47.82	0.00
Price to Tangible Book Value (P/TBV)	4.45	3.39	2.13	2.69	3.43	3.19	4.75	40.65	166.62	0.00
Price to Revenue (P/Rev)	4.47	4.08	3.21	4.03	6.31	5.34	6.81	19.88	22.31	34.47
Price to Earnings (P/E)	18.61	35.91	28.38	25.03	55.70	16.10	8.42	58.32	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	5.37%	2.79%	3.52%	4.00%	1.80%	6.21%	11.87%	1.71%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	16.05	10.62	7.35	10.59	13.72	12.71	11.38	0.00	0.00	60.71
Enterprise Value to Revenue (EV/Rev)	3.67	3.13	1.93	2.75	4.75	3.91	5.81	18.87	20.79	38.90
Enterprise Value to EBITDA (EV/EBITDA)	12.56	29.16	13.99	13.15	39.04	9.99	11.17	52.19	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	13.16	33.55	15.44	13.77	42.26	10.21	11.29	52.58	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	17.20	41.61	19.84	17.52	49.87	12.69	7.41	52.91	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	11.36	17.21	8.57	9.84	22.44	7.17	11.93	51.55	18.92	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	15.70	270.54	29.35	20.28	94.65	8.66	80.35	64.45	19.39	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.12	-2.97
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-2.97
Financial Leverage	-0.77	-0.80	-0.83	-0.83	-0.82	-0.75	-0.83	-2.00	2.44	-1.09
Leverage Ratio	1.31	1.27	1.21	1.16	1.13	1.11	1.32	3.34	-18.03	-2.56
Compound Leverage Factor	1.47	1.91	1.41	1.19	1.33	1.20	1.36	3.26	-31.85	-3.40
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	67.92%	150.81%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	67.92%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	150.81%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	32.08%	-50.81%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-6.24	-4.04
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.58	-1.59
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-4.04
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-9.61	-4.92
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	14.75	-1.94
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-4.92
Altman Z-Score	10.07	7.71	6.56	10.04	15.50	16.83	27.28	12.85	0.90	-7.07
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.63	3.34	4.99	5.43	7.06	7.08	8.50	4.21	1.74	3.42
Quick Ratio	3.41	3.13	4.70	5.18	6.68	6.80	8.12	4.07	1.71	3.30
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	507	21	106	195	50	436	62	132	205	-109
Operating Cash Flow to CapEx	2,461.65%	823.65%	1,308.79%	739.15%	688.69%	4,105.94%	1,260.18%	789.41%	13,101.12%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.26	6.21	-2.69
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	19.08	6.36	-3.47
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	16.66	6.32	-3.45
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.74	0.61	0.57	0.60	0.49	0.59	0.82	0.72	0.41	0.11
Accounts Receivable Turnover	8.63	8.09	6.48	6.47	7.06	6.87	7.00	7.44	8.39	7.39
Inventory Turnover	3.84	2.87	1.91	2.18	2.14	2.91	3.19	3.01	2.20	1.56
Fixed Asset Turnover	17.48	15.29	15.01	16.74	16.99	19.40	22.28	32.54	109.25	19.23
Accounts Payable Turnover	2.12	2.18	2.03	2.21	2.06	2.94	2.57	1.87	1.01	0.61
Days Sales Outstanding (DSO)	42.32	45.09	56.35	56.41	51.74	53.15	52.15	49.06	43.49	49.42
Days Inventory Outstanding (DIO)	95.09	127.35	191.59	167.29	170.36	125.30	114.25	121.07	165.84	234.13
Days Payable Outstanding (DPO)	172.31	167.12	179.40	165.30	177.17	123.97	141.83	195.51	361.16	600.40
Cash Conversion Cycle (CCC)	-34.90	5.31	68.54	58.40	44.92	54.48	24.57	-25.38	-151.82	-316.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	496	540	423	372	342	297	436	-172	-201	24
Invested Capital Turnover	4.19	3.80	4.05	4.02	3.09	2.64	6.48	-2.42	-2.16	3.20
Increase / (Decrease) in Invested Capital	-44	117	51	31	44	-139	608	29	-225	24
Enterprise Value (EV)	7,953	5,736	3,109	3,946	4,689	3,780	4,961	8,537	3,981	1,446
Market Capitalization	9,701	7,460	5,174	5,784	6,227	5,168	5,812	8,994	4,271	1,282
Book Value per Share	$7.86	$7.28	$7.71	$6.99	$6.06	$5.55	$4.31	$0.96	$0.31	($0.62)
Tangible Book Value per Share	$7.64	$7.08	$7.52	$6.79	$5.85	$5.34	$4.09	$0.75	$0.09	($0.90)
Total Capital	2,244	2,264	2,488	2,211	1,879	1,686	1,287	285	278	277
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	189	418
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	418
Net Debt	-1,749	-1,724	-2,065	-1,838	-1,537	-1,389	-852	-457	-290	165
Capital Expenditures (CapEx)	28	40	28	54	30	13	33	21	1.61	-0.90
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-47	-72	-14	30	34	16	98	-19	-30	-41
Debt-free Net Working Capital (DFNWC)	1,064	924	1,294	1,497	1,241	868	792	370	389	126
Net Working Capital (NWC)	1,064	924	1,294	1,497	1,241	868	792	370	200	126
Net Nonoperating Expense (NNE)	-59	-70	-26	-5.88	-18	-23	-20	7.13	51	77
Net Nonoperating Obligations (NNO)	-1,749	-1,724	-2,065	-1,838	-1,537	-1,389	-852	-457	-290	165
Total Depreciation and Amortization (D&A)	29	26	21	14	9.14	8.35	4.92	1.19	9.43	18
Debt-free, Cash-free Net Working Capital to Revenue	-2.19%	-3.91%	-0.87%	2.10%	3.46%	1.67%	11.50%	-4.10%	-15.91%	-109.35%
Debt-free Net Working Capital to Revenue	49.05%	50.47%	80.34%	104.33%	125.64%	89.74%	92.71%	81.71%	203.36%	340.08%
Net Working Capital to Revenue	49.05%	50.47%	80.34%	104.33%	125.64%	89.74%	92.71%	81.71%	104.58%	340.08%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.80	$0.65	$0.57	$0.73	$0.36	$1.06	$2.32	$0.52	($0.28)	($0.81)
Adjusted Weighted Average Basic Shares Outstanding	290.03M	318.15M	321.53M	314.88M	308.27M	302.58M	297.89M	293.59M	290.87M	228.19M
Adjusted Diluted Earnings per Share	$1.76	$0.65	$0.56	$0.72	$0.35	$1.02	$2.21	$0.49	($0.28)	($0.81)
Adjusted Weighted Average Diluted Shares Outstanding	296.13M	321.46M	324.56M	322.36M	318.00M	315.01M	312.80M	312.00M	290.87M	228.19M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	($0.28)	($0.81)
Adjusted Weighted Average Basic & Diluted Shares Outstanding	279.88M	303.19M	324.09M	319.45M	311.99M	305.39M	300.13M	296.31M	250.53M	209.23M
Normalized Net Operating Profit after Tax (NOPAT)	528	138	157	225	94	298	307	161	-19	-84
Normalized NOPAT Margin	24.33%	7.53%	9.73%	15.69%	9.52%	30.78%	35.98%	35.66%	-9.95%	-226.69%
Pre Tax Income Margin	31.43%	14.07%	14.55%	20.50%	13.25%	41.14%	52.95%	35.05%	-36.68%	-434.98%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	18.71	-1.20	-2.99
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	18.59	-0.60	-2.09
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	16.29	-1.25	-2.97
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	16.17	-0.64	-2.07
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	125.09%	264.90%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Exelixis' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/3/2025	9/27/2024	6/28/2024	3/29/2024	12/29/2023	9/29/2023	6/30/2023	3/31/2023	12/30/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	18.16%	14.33%	35.61%	4.02%	13.15%	14.62%	12.02%	14.83%	-6.03%	25.37%
EBITDA Growth	94.06%	1,404.78%	237.27%	0.34%	307.63%	-112.47%	-5.24%	-59.46%	-135.84%	56.38%
EBIT Growth	100.22%	886.67%	254.02%	2.07%	268.65%	-120.95%	-7.05%	-65.50%	-141.53%	59.96%
NOPAT Growth	81.99%	3,397.21%	238.36%	-6.64%	301.70%	-104.79%	-5.81%	-64.31%	-135.78%	77.46%
Net Income Growth	63.55%	11,232.66%	178.54%	-6.77%	383.43%	-98.58%	14.87%	-41.63%	-131.71%	91.63%
EPS Growth	67.86%	0.00%	208.00%	0.00%	380.00%	-100.00%	13.64%	-42.86%	-133.33%	91.67%
Operating Cash Flow Growth	2,172.85%	131.19%	-1.18%	-18.47%	-85.66%	6.63%	288.62%	-42.86%	-23.60%	32.13%
Free Cash Flow Firm Growth	443.95%	38.29%	-251.80%	16.23%	42.24%	-309.53%	30.29%	-163.87%	-233.10%	566.80%
Invested Capital Growth	-8.20%	30.12%	62.23%	22.92%	27.57%	10.16%	7.66%	36.49%	13.64%	13.00%
Revenue Q/Q Growth	5.04%	-15.32%	49.84%	-11.35%	1.64%	0.44%	14.94%	-3.57%	2.96%	-1.83%
EBITDA Q/Q Growth	19.25%	-49.28%	691.35%	-59.46%	901.75%	-113.11%	135.43%	183.90%	-148.15%	-0.36%
EBIT Q/Q Growth	20.16%	-50.63%	838.23%	-64.03%	572.13%	-122.22%	170.52%	159.44%	-158.65%	-1.44%
NOPAT Q/Q Growth	19.09%	-51.30%	854.53%	-67.12%	2,257.62%	-105.00%	163.37%	171.03%	-151.22%	-1.69%
Net Income Q/Q Growth	18.55%	-47.83%	505.93%	-56.36%	8,114.99%	-98.72%	102.80%	232.66%	-141.21%	3.59%
EPS Q/Q Growth	17.50%	-48.05%	541.67%	-57.14%	0.00%	-100.00%	108.33%	220.00%	-143.48%	4.55%
Operating Cash Flow Q/Q Growth	-11.45%	126.97%	73.71%	551.05%	-90.99%	-2.98%	43.33%	14.54%	-33.05%	253.59%
Free Cash Flow Firm Q/Q Growth	731.96%	46.80%	35.59%	-58.84%	-13.39%	-230.86%	135.55%	-9.52%	-511.30%	-18.63%
Invested Capital Q/Q Growth	-11.94%	-17.89%	28.07%	-0.87%	24.82%	2.38%	-2.96%	2.87%	7.78%	0.06%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	96.48%	96.79%	97.23%	95.00%	95.46%	96.02%	96.23%	96.50%	96.24%	96.28%
EBITDA Margin	30.19%	26.60%	44.40%	8.41%	18.38%	-2.33%	17.85%	8.72%	-10.02%	21.42%
Operating Margin	28.80%	25.22%	43.30%	6.93%	17.05%	-3.73%	16.57%	7.05%	-11.34%	20.06%
EBIT Margin	28.84%	25.22%	43.25%	6.91%	17.02%	-3.66%	16.57%	7.04%	-11.42%	20.05%
Profit (Net Income) Margin	24.68%	21.87%	35.49%	8.78%	17.83%	0.22%	17.28%	9.79%	-7.12%	17.78%
Tax Burden Percent	75.69%	76.23%	77.21%	75.74%	83.00%	17.89%	80.87%	82.91%	96.01%	79.54%
Interest Burden Percent	113.03%	113.75%	106.26%	167.73%	126.19%	-33.64%	128.96%	167.77%	64.91%	111.51%
Effective Tax Rate	24.31%	23.77%	22.79%	24.26%	17.00%	82.11%	19.13%	17.09%	0.00%	20.46%
Return on Invested Capital (ROIC)	91.30%	80.41%	121.54%	19.97%	53.79%	-2.87%	56.37%	25.79%	-32.15%	70.65%
ROIC Less NNEP Spread (ROIC-NNEP)	90.36%	79.63%	120.80%	19.16%	52.86%	-3.08%	55.48%	25.01%	-32.33%	70.26%
Return on Net Nonoperating Assets (RNNOA)	-69.60%	-62.48%	-92.00%	-15.19%	-42.14%	2.55%	-46.29%	-21.12%	26.85%	-58.96%
Return on Equity (ROE)	21.70%	17.93%	29.54%	4.78%	11.64%	-0.32%	10.08%	4.68%	-5.30%	11.68%
Cash Return on Invested Capital (CROIC)	97.85%	55.64%	4.31%	7.47%	4.40%	-2.23%	19.82%	-0.49%	26.62%	67.10%
Operating Return on Assets (OROA)	21.24%	17.68%	29.45%	4.29%	10.36%	-2.19%	9.43%	4.04%	-6.47%	12.14%
Return on Assets (ROA)	18.17%	15.33%	24.16%	5.45%	10.85%	0.13%	9.83%	5.62%	-4.03%	10.77%
Return on Common Equity (ROCE)	21.70%	17.93%	29.54%	4.78%	11.64%	-0.32%	10.08%	4.68%	-5.30%	11.68%
Return on Equity Simple (ROE_SIMPLE)	0.00%	20.52%	16.51%	9.64%	0.00%	3.92%	6.50%	6.02%	0.00%	12.35%
Net Operating Profit after Tax (NOPAT)	124	104	213	22	68	-3.15	63	24	-34	66
NOPAT Margin	21.80%	19.23%	33.43%	5.25%	14.15%	-0.67%	13.40%	5.85%	-7.94%	15.96%
Net Nonoperating Expense Percent (NNEP)	0.94%	0.79%	0.74%	0.81%	0.93%	0.21%	0.89%	0.79%	0.18%	0.39%
Return On Investment Capital (ROIC_SIMPLE)	5.50%	-	-	-	3.00%	-	-	-	-1.35%	-
Cost of Revenue to Revenue	3.52%	3.21%	2.77%	5.00%	4.54%	3.98%	3.77%	3.50%	3.76%	3.72%
SG&A Expenses to Revenue	23.70%	20.72%	20.72%	26.81%	27.40%	29.27%	30.16%	32.14%	28.13%	27.93%
R&D to Revenue	43.93%	41.25%	33.14%	53.55%	51.01%	70.47%	49.50%	57.30%	79.46%	48.29%
Operating Expenses to Revenue	67.68%	71.57%	53.93%	88.07%	78.41%	99.75%	79.66%	89.45%	107.59%	76.22%
Earnings before Interest and Taxes (EBIT)	163	136	276	29	82	-17	78	29	-48	83
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	171	144	283	36	88	-11	84	36	-42	88
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.32	3.25	3.09	3.47	3.30	2.96	2.46	2.46	2.08	2.03
Price to Tangible Book Value (P/TBV)	4.45	3.35	3.18	3.57	3.39	3.05	2.53	2.52	2.13	2.08
Price to Revenue (P/Rev)	4.47	3.56	3.25	4.00	4.08	3.92	3.63	3.78	3.21	3.08
Price to Earnings (P/E)	18.61	15.86	18.70	35.99	35.91	75.55	37.89	40.92	28.38	16.40
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	5.37%	6.31%	5.35%	2.78%	2.79%	1.32%	2.64%	2.44%	3.52%	6.10%
Enterprise Value to Invested Capital (EV/IC)	16.05	10.11	7.46	10.81	10.62	11.66	9.75	9.58	7.35	7.51
Enterprise Value to Revenue (EV/Rev)	3.67	2.73	2.54	3.13	3.13	2.84	2.40	2.51	1.93	1.80
Enterprise Value to EBITDA (EV/EBITDA)	12.56	10.34	12.91	29.40	29.16	76.33	24.92	24.55	13.99	7.69
Enterprise Value to EBIT (EV/EBIT)	13.16	10.89	13.84	33.73	33.55	123.23	29.25	28.44	15.44	8.05
Enterprise Value to NOPAT (EV/NOPAT)	17.20	13.98	17.82	42.53	41.61	164.26	37.15	36.41	19.84	10.04
Enterprise Value to Operating Cash Flow (EV/OCF)	11.36	12.10	16.16	18.21	17.21	12.72	10.58	13.94	8.57	7.65
Enterprise Value to Free Cash Flow (EV/FCFF)	15.70	20.56	214.08	159.64	270.54	0.00	50.99	0.00	29.35	11.87
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.77	-0.78	-0.76	-0.79	-0.80	-0.83	-0.83	-0.84	-0.83	-0.84
Leverage Ratio	1.31	1.28	1.27	1.27	1.27	1.23	1.22	1.20	1.21	1.17
Compound Leverage Factor	1.48	1.46	1.35	2.13	1.60	-0.41	1.58	2.01	0.79	1.31
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	9.58	7.77	7.45	7.51	7.61	7.58	7.19	7.48	6.29	7.71
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.63	3.93	4.27	3.46	3.34	3.83	4.68	5.00	4.99	6.10
Quick Ratio	3.41	3.70	4.05	3.23	3.13	3.59	4.42	4.72	4.70	5.84
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	168	-27	-50	-77	-49	-43	33	-92	-84	21
Operating Cash Flow to CapEx	6,041.31%	3,310.21%	1,819.60%	710.16%	80.48%	1,252.18%	2,037.70%	702.00%	758.40%	2,182.65%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.74	0.70	0.68	0.62	0.61	0.60	0.57	0.57	0.57	0.61
Accounts Receivable Turnover	8.63	8.04	6.40	7.78	8.09	7.66	7.32	7.84	6.48	8.31
Inventory Turnover	3.84	3.39	3.23	3.12	2.87	2.58	2.05	2.02	1.91	2.00
Fixed Asset Turnover	17.48	16.96	16.43	15.17	15.29	15.50	15.34	14.96	15.01	15.77
Accounts Payable Turnover	2.12	1.82	2.91	2.71	2.18	2.34	2.75	2.37	2.03	2.00
Days Sales Outstanding (DSO)	42.32	45.40	57.03	46.89	45.09	47.63	49.85	46.56	56.35	43.95
Days Inventory Outstanding (DIO)	95.09	107.60	113.13	117.13	127.35	141.40	177.91	180.50	191.59	182.65
Days Payable Outstanding (DPO)	172.31	200.64	125.58	134.75	167.12	155.99	132.66	154.32	179.40	182.43
Cash Conversion Cycle (CCC)	-34.90	-47.64	44.58	29.27	5.31	33.04	95.10	72.75	68.54	44.16
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	496	563	685	535	540	433	423	435	423	393
Invested Capital Turnover	4.19	4.18	3.64	3.81	3.80	4.30	4.21	4.41	4.05	4.43
Increase / (Decrease) in Invested Capital	-44	130	263	100	117	40	30	116	51	45
Enterprise Value (EV)	7,953	5,693	5,111	5,787	5,736	5,042	4,117	4,171	3,109	2,948
Market Capitalization	9,701	7,405	6,545	7,379	7,460	6,957	6,223	6,291	5,174	5,046
Book Value per Share	$7.86	$7.98	$7.28	$7.08	$7.28	$7.37	$7.76	$7.88	$7.71	$7.74
Tangible Book Value per Share	$7.64	$7.75	$7.06	$6.86	$7.08	$7.17	$7.57	$7.69	$7.52	$7.54
Total Capital	2,244	2,275	2,120	2,128	2,264	2,348	2,528	2,555	2,488	2,491
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-1,749	-1,713	-1,434	-1,593	-1,724	-1,915	-2,105	-2,120	-2,065	-2,099
Capital Expenditures (CapEx)	3.98	8.20	6.57	9.69	13	9.37	5.94	12	9.72	5.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-47	-34	130	-44	-72	-37	-16	-3.11	-14	-7.10
Debt-free Net Working Capital (DFNWC)	1,064	1,155	1,132	919	924	1,067	1,251	1,310	1,294	1,540
Net Working Capital (NWC)	1,064	1,155	1,132	919	924	1,067	1,251	1,310	1,294	1,540
Net Nonoperating Expense (NNE)	-16	-14	-13	-15	-18	-4.19	-18	-16	-3.48	-7.50
Net Nonoperating Obligations (NNO)	-1,749	-1,713	-1,434	-1,593	-1,724	-1,915	-2,105	-2,120	-2,065	-2,099
Total Depreciation and Amortization (D&A)	7.64	7.45	7.33	6.38	6.53	6.30	6.04	6.86	5.95	5.66
Debt-free, Cash-free Net Working Capital to Revenue	-2.19%	-1.62%	6.44%	-2.37%	-3.91%	-2.08%	-0.93%	-0.19%	-0.87%	-0.43%
Debt-free Net Working Capital to Revenue	49.05%	55.50%	56.19%	49.79%	50.47%	60.11%	72.97%	78.73%	80.34%	93.99%
Net Working Capital to Revenue	49.05%	55.50%	56.19%	49.79%	50.47%	60.11%	72.97%	78.73%	80.34%	93.99%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.49	$0.41	$0.78	$0.12	$0.28	$0.00	$0.25	$0.12	($0.09)	$0.23
Adjusted Weighted Average Basic Shares Outstanding	290.03M	285.62M	289.22M	300.76M	318.15M	315.50M	324.21M	324.42M	321.53M	322.15M
Adjusted Diluted Earnings per Share	$0.47	$0.40	$0.77	$0.12	$0.28	$0.00	$0.25	$0.12	($0.10)	$0.23
Adjusted Weighted Average Diluted Shares Outstanding	296.13M	291.48M	293.97M	305.53M	321.46M	319.25M	327.31M	326.28M	324.56M	325.07M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	279.88M	285.58M	285.25M	291.29M	303.19M	310.97M	318.38M	325.64M	324.09M	322.56M
Normalized Net Operating Profit after Tax (NOPAT)	124	143	213	47	68	-12	63	24	-34	66
Normalized NOPAT Margin	21.83%	26.54%	33.49%	11.10%	14.15%	-2.61%	13.40%	5.85%	-7.94%	15.96%
Pre Tax Income Margin	32.60%	28.68%	45.96%	11.59%	21.48%	1.23%	21.37%	11.81%	-7.41%	22.35%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	125.09%	143.69%	250.24%	358.81%	264.90%	370.44%	75.64%	0.00%	0.00%	0.00%

Frequently Asked Questions About Exelixis' Financials

When does Exelixis's financial year end?

According to the most recent income statement we have on file, Exelixis' fiscal year ends in January. Their fiscal year 2025 ended on January 3, 2025.

How has Exelixis' net income changed over the last 9 years?

Exelixis' net income appears to be on an upward trend, with a most recent value of $521.27 million in 2024, falling from -$161.74 million in 2015. The previous period was $207.77 million in 2023. See Exelixis' forecast for analyst expectations on what’s next for the company.

What is Exelixis's operating income?

Exelixis's total operating income in 2024 was $604.62 million, based on the following breakdown:

Total Gross Profit: $2.09 billion
Total Operating Expenses: $1.49 billion

How has Exelixis revenue changed over the last 9 years?

Over the last 9 years, Exelixis' total revenue changed from $37.17 million in 2015 to $2.17 billion in 2024, a change of 5,734.2%.

How much debt does Exelixis have?

Exelixis' total liabilities were at $703.49 million at the end of 2024, a 3.7% increase from 2023, and a 48.7% increase since 2015.

How much cash does Exelixis have?

In the past 9 years, Exelixis' cash and equivalents has ranged from $141.63 million in 2015 to $647.17 million in 2021, and is currently $217.37 million as of their latest financial filing in 2024.

How has Exelixis' book value per share changed over the last 9 years?

Over the last 9 years, Exelixis' book value per share changed from -0.62 in 2015 to 7.86 in 2024, a change of -1,368.1%.

Related Companies

This page (NASDAQ:EXEL) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Exelixis (EXEL) Financials

Frequently Asked Questions About Exelixis' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Exelixis (EXEL) Financials

Annual Income Statements for Exelixis

Quarterly Income Statements for Exelixis

Annual Cash Flow Statements for Exelixis

Quarterly Cash Flow Statements for Exelixis

Annual Balance Sheets for Exelixis

Quarterly Balance Sheets for Exelixis

Annual Metrics And Ratios for Exelixis

Quarterly Metrics And Ratios for Exelixis

Frequently Asked Questions About Exelixis' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools